OAM
BBH icon

Occidental Asset Management’s VanEck Biotech ETF BBH Stock Holding History

Occidental Asset Management’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,601
Closed -$432K – 157
2018
Q2 		$432K Sell
3,601
-44
-1% -$5.18K 0.23% 86
2018
Q1 		$439K Buy
3,645
+73
+2% +$9.16K 0.24% 74
2017
Q4 		$445K Buy
+3,572
New +$456K 0.23% 75

Other funds holding BBH

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Occidental Asset Management's BBH Position: Q3 2018 in Review

Occidental Asset Management sold out of VanEck Biotech ETF (BBH) in Q3 2018, closing a stake of 3,601 shares — an estimated $432K sold.

Occidental Asset Management first reported a position in BBH in Q4 2017 and held it in 3 quarters. The position peaked at $445K in Q4 2017. 84 funds tracked by Wall St. Rank hold BBH as of Q3 2018.

  • Occidental Asset Management reported no remaining VanEck Biotech ETF position as of Q3 2018 after selling out during the quarter.
  • Occidental Asset Management sold 3,601 VanEck Biotech ETF shares in Q3 2018, an estimated $432K.
  • Occidental Asset Management first reported a position in VanEck Biotech ETF in Q4 2017 and held it in 3 quarters.
  • Occidental Asset Management's VanEck Biotech ETF position peaked at $445K in Q4 2017.
  • 84 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2018.

Based on Occidental Asset Management's 13F filing for Q3 2018, filed 19 Mar 2019.